Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Patrick P.M. Honoré, David De Bels and Herbert D. M. Spapen

ULB Institutional Repository from ULB -- Universite Libre de Bruxelles

Keywords: Antioxidant therapy; Astragaloside IV; Crush syndrome; Ischemia–reperfusion injury; Rhabdomyolysis (search for similar items in EconPapers)
Date: 2018-12
Note: SCOPUS: ed.j
References: View complete reference list from CitEc
Citations:

Published in: Annals of intensive care (2018) v.8 n° 1

Downloads: (external link)
https://dipot.ulb.ac.be/dspace/bitstream/2013/283098/1/doi_266725.pdf Full text for the whole work, or for a work part (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ulb:ulbeco:2013/283098

Ordering information: This working paper can be ordered from
http://hdl.handle.ne ... lb.ac.be:2013/283098

Access Statistics for this paper

More papers in ULB Institutional Repository from ULB -- Universite Libre de Bruxelles Contact information at EDIRC.
Bibliographic data for series maintained by Benoit Pauwels ().